Verastem Stock (NASDAQ: VSTM) stock price, news, charts, stock research, profile.
Open | $4.050 |
Close | $3.960 |
Volume / Avg. | 979.689K / 553.901K |
Day Range | 3.920 - 4.082 |
52 Wk Range | 3.860 - 15.180 |
Market Cap | $101.302M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 21 |
Short Interest | 3.22% |
Days to Cover | 6.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verastem (NASDAQ: VSTM) through any online brokerage.
Other companies in Verastem’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), T2 Biosystems (NASDAQ:TTOO), FibroGen (NASDAQ:FGEN) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Verastem (NASDAQ: VSTM) was reported by Alliance Global Partners on Wednesday, May 29, 2024. The analyst firm set a price target for 20.00 expecting VSTM to rise to within 12 months (a possible 400.00% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Verastem (NASDAQ: VSTM) is $4 last updated May 31, 2024 at 7:57 PM EDT.
There are no upcoming dividends for Verastem.
Verastem’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Verastem.
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.